
Clarification17 Nov 2026, 12:17 pm
Indraprastha Medical Corp Denies Price Sensitive Information
AI Summary
Indraprastha Medical Corporation Ltd has responded to an exchange query regarding a recent increase in share volume. The company stated that there is no impending or existing information, including price-sensitive details, that would warrant disclosure under SEBI regulations and could impact the company's operations or performance. They are unaware of any specific reasons that led to the observed movement in share price or volume.
Key Highlights
- Company denies any price-sensitive information.
- No impending announcements that could affect operations.
- Unaware of reasons for share price/volume movement.
- Compliance with SEBI Listing Regulations confirmed.
Price Impact
More from INDRAMEDCO